Genmab | GEN - Debt

Stock Price
2,044.00
Daily Change
-53.00 -2.53%
Monthly
1.69%
Yearly
45.74%
Q1 Forecast
1,920.90

Genmab reported DKK148M in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Agios Pharmaceuticals USD 48.76M 47.62M Jun/2025
Amarin USD 0 0 Mar/2025
Amgen USD 54.59B 1.62B Sep/2025
argenx SE USD 43.15M 4.1M Jun/2025
AstraZeneca USD 32.84B 1.19B Jun/2025
Bayer EUR 39.39B 1.31B Mar/2025
BioMarin Pharmaceutical USD 603.87M 8.22M Jun/2025
Demant DKK 16.18B 498M Jun/2025
Fresenius Medical Care EUR 11.02B 203.55M Jun/2025
Galapagos EUR 10.86M 864K Mar/2025
Genmab DKK 148M 5M Jun/2025
GlaxoSmithKline GBP 17.35B 1.08B Jun/2025
GN Store Nord DKK 11.79B 15M Jun/2025
GRIFOLS EUR 8.82B 1.23B Jun/2025
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
Insmed USD 564.56M 464K Sep/2025
Lonza CHF 4.71B 915M Dec/2024
Merck EUR 9.4B 704M Jun/2025
Novartis USD 32.64B 1.37B Jun/2025
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025
UCB EUR 3.03B 12M Dec/2024